7121 Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)

✍ Scribed by Bellmunt, J.; Melichar, B.; Bracarda, S.; Negrier, S.N.; Ravaud, A.; Laeufle, R.; Sneller, V.; Escudier, B.

• Book ID: 123431079
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71454-5